Klaus Scheja
Director/Board Member presso STADA ARZNEIMITTEL
Profilo
Klaus Scheja is a Member-Supervisory Board at STADA Arzneimittel AG since 2019.
He was previously a Manager-Marketing & Sales at Norgine GmbH from 1995 to 1999.
He also worked as a Manager-Key Account at R.P.
Scherer GmbH & Co. KG.
Dr. Scheja earned a doctorate degree from Philipps University of Marburg in 1993.
Posizioni attive di Klaus Scheja
Società | Posizione | Inizio |
---|---|---|
STADA ARZNEIMITTEL | Director/Board Member | 01/01/2019 |
Precedenti posizioni note di Klaus Scheja
Società | Posizione | Fine |
---|---|---|
Norgine GmbH
Norgine GmbH Pharmaceuticals: MajorHealth Technology Part of Norgine Europe BV, Norgine GmbH develops and markets medicines and medical devices. The private company is based in Wettenberg, Germany. The CEOs of the German company are Christopher William Bath, Kenneth Eric Scrimgeour, Kenneth MacRitchie. | Sales & Marketing | 01/01/1999 |
R.P. Scherer GmbH & Co. KG
R.P. Scherer GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Part of Catalent, Inc., R.P. Scherer GmbH & Co. KG develops, manufactures and sells pharmaceutical products. The private company is based in Eberbach, Germany. | Comptroller/Controller/Auditor | - |
Formazione di Klaus Scheja
Philipps University of Marburg | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
STADA Arzneimittel AG
STADA Arzneimittel AG Pharmaceuticals: OtherHealth Technology STADA Arzneimittel AG engages in the provision of healthcare and pharmaceutical products. It operates through the following segments: Generics, Consumer Healthcare, and Specialty. The Generics segment produces and distributes generic drugs. The Consumer Healthcare segment includes products such as OTC drugs, nutritional supplements and certain consumer healthcare products such as disinfectants and sunscreen. The Specialty segment includes branded generics, specialty generics, and biosimilars. Its brands include Zoflora, Grippostad, Nizoral, and Shampoo & Ladival. The company was founded on March 14, 1895 and is headquartered in Bad Vilbel, Germany. | Health Technology |
Norgine GmbH
Norgine GmbH Pharmaceuticals: MajorHealth Technology Part of Norgine Europe BV, Norgine GmbH develops and markets medicines and medical devices. The private company is based in Wettenberg, Germany. The CEOs of the German company are Christopher William Bath, Kenneth Eric Scrimgeour, Kenneth MacRitchie. | Health Technology |
R.P. Scherer GmbH & Co. KG
R.P. Scherer GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Part of Catalent, Inc., R.P. Scherer GmbH & Co. KG develops, manufactures and sells pharmaceutical products. The private company is based in Eberbach, Germany. | Health Technology |
- Borsa valori
- Insiders
- Klaus Scheja